Best Doctors for CAR T-Cell Therapy in India

Dr. Ashok K. Vaid is a distinguished medical oncologist and stem cell transplant specialist with more than four decades of clinical experience. He currently serves as Chairman, Medical Oncology, Hematology and Stem Cell Transplant at the Medanta Cancer Institute, Gurgaon — one of India's largest cancer programmes. Dr. Vaid established one of the largest stem cell transplant programmes in the private sector in north India. His clinical interests centre on cancer genomics, immunotherapy guidance, precision onco-therapeutics, dendritic cell therapy, and stem cell transplantation. He has performed and supervised some of the earliest bone marrow transplants in the country, including the first 25 BMTs done at his earlier institution. He earned his Doctor of Medicine (DM) in Medical Oncology from Tamil Nadu Dr. MGR Medical University, Chennai, and has authored several peer-reviewed publications. Dr. Vaid has served as Principal Investigator for more than 50 international and national clinical studies, and is a registered postgraduate teacher with the National Board of Examinations and a panel examiner for super-specialty Medical Oncology. In recognition of his exceptional contribution to medicine, the Government of India conferred upon him the prestigious Padma Shri Award in 2009.

Dr. Saveena Gulati Raheja is a Senior Consultant in Medical Oncology with more than 37 years of dedicated clinical experience in comprehensive cancer care. She earned her medical qualifications from the prestigious Maulana Azad Medical College, Delhi, including her MBBS and MD, and holds specialized certifications in board-certified cancer pain management (BCCPM) and palliative care (IAPC). Her extensive background positions her as a trusted voice in oncology across India and internationally. Dr. Raheja's clinical expertise spans the full spectrum of modern cancer treatment modalities: conventional chemotherapy, targeted molecular therapies, cancer immunotherapy, and CAR-T cell therapy. She specializes in hormone-directed treatments for breast, prostate, and gynecologic malignancies, and is particularly skilled in managing treatment-related side effects through integrative approaches including acupuncture and supportive care. Her holistic philosophy combines evidence-based oncology with patient-centric supportive strategies, allowing her to address not only disease control but also quality of life during and after treatment. Dr. Raheja has built a reputation for welcoming and effectively managing international patients from the Gulf Cooperation Council nations, Africa, and South Asian regions. She is fluent in English, Hindi, and Punjabi, facilitating clear communication with patients from diverse backgrounds. Her patient-first approach and emphasis on informed decision-making make her particularly valued by overseas patients seeking comprehensive cancer management in India. Practicing at Indraprastha Apollo Hospital in New Delhi, Dr. Raheja benefits from access to state-of-the-art oncology infrastructure, advanced diagnostic imaging, and multidisciplinary tumor boards. Apollo's commitment to international patient services, combined with its NABH-accredited facilities and 24/7 critical care support, creates an ideal environment for complex cancer cases. International patients choosing Dr. Raheja's care will find seamless coordination, English-speaking nursing staff, and dedicated international patient liaison teams to arrange consultations, treatment planning, and post-operative follow-up. Her pioneering work in establishing palliative care units underscores her commitment to dignified, compassionate cancer care—a philosophy especially valued by patients and families navigating advanced disease from abroad.

Dr. Harsh Dua is a Senior Consultant Medical Oncologist at Indraprastha Apollo Hospital in New Delhi, bringing over 35 years of dedicated clinical experience in comprehensive cancer care. Holding qualifications in MBBS and MD, he has established himself as a trusted oncology specialist delivering evidence-based treatment and compassionate patient management across a broad spectrum of malignancies. Dr. Dua's clinical expertise spans the full range of modern oncology practice, including chemotherapy administration, cancer immunotherapy, targeted molecular therapies, hormone therapy for breast and prostate cancers, CAR-T cell therapy, and advanced radiation techniques including brachytherapy and stereotactic body radiation therapy. His patient-centric approach ensures that each treatment plan is individually tailored to the patient's clinical profile, disease stage, and personal circumstances. Throughout his career, he has maintained a focus on staying current with the latest advances in oncology, enabling him to offer cutting-edge therapeutic options alongside conventional care. Dr. Dua regularly treats patients from across India, the Gulf region, and international destinations seeking specialized cancer treatment in Delhi. He is fluent in English and Hindi, facilitating clear communication with diverse patient populations. His commitment to patient education empowers individuals and families to understand their diagnoses and participate actively in treatment decisions, fostering a collaborative relationship built on trust and transparency. Indraprastha Apollo Hospital, where Dr. Dua practices, is a leading multi-specialty tertiary care centre equipped with state-of-the-art oncology facilities, including dedicated chemotherapy units, advanced radiation therapy suites, and comprehensive supportive care services. The hospital's robust infrastructure, coupled with Dr. Dua's extensive experience, makes it an ideal destination for international patients seeking world-standard cancer care in India. For those considering treatment abroad, Gaf Healthcare facilitates seamless coordination of consultations, medical records transfer, and treatment logistics.

Dr. J. Jebasingh is a Senior Consultant in Medical Oncology at the Cancer Centre of Rela Institute & Medical Centre in Chennai, India, with more than 33 years of clinical expertise in comprehensive cancer care. He holds a DM in Medical Oncology from Madras Medical College (2006), an MD in Radiotherapy from Madurai Medical College (1999), a DNB in General Medicine from Meenakshi Mission Hospital & Research Centre (2000), and an MBBS from the prestigious Christian Medical College (1993). His deep foundation across radiotherapy, general medicine, and medical oncology positions him uniquely to manage complex malignancies with integrated, evidence-based approaches. Dr. Jebasingh specializes in chemotherapy, cancer immunotherapy, targeted therapy, and hormone therapies for breast, gynecologic, and prostate cancers. He brings particular expertise in bone marrow transplantation and emerging CAR-T cell therapy. His clinical career has been enriched by active participation in rigorous clinical trials, including bio-equivalence studies of liposomal doxorubicin and temozolomide, and maintenance pemetrexed protocols in non-squamous lung cancer. He has presented findings at nearly 40 international and regional oncology conferences and has authored research on nasopharyngeal cancer, neo-adjuvant response assessment in osteosarcoma, and glucose tolerance outcomes in cancer populations. This combination of bedside practice and investigative rigor ensures his patients benefit from the latest therapeutic advances. Dr. Jebasingh has trained extensively in specialized oncology domains, including bone marrow transplantation at Cancer Institute, Adyar, and pediatric and gynecological oncology at the Institute of Child Health and Institute of Obstetrics & Gynaecology, Chennai. He maintains currency through continuing medical education, having completed a Johns Hopkins University certification on breast cancer updates. He welcomes international patients from the Gulf, Africa, and South Asia, offering compassionate, personalized cancer management with fluency in English, Hindi, and Tamil. His holistic approach integrates supportive care alongside curative and palliative strategies. Rela Institute & Medical Centre is one of India's leading multi-specialty hospitals, accredited by JCI and NABH, with state-of-the-art oncology facilities, dedicated ICU support, and an established international patient services desk. The hospital's cancer centre combines cutting-edge diagnostic imaging, advanced chemotherapy infusion units, and hematology-oncology laboratories. For international patients, the hospital arranges rapid visa documentation support, accommodation coordination, and flexible telemedicine follow-ups. Dr. Jebasingh's 33+ years of dedicated oncology practice, combined with Rela's world-standard infrastructure and patient-centric services, makes Chennai an increasingly preferred destination for complex cancer care among patients across Asia, the Middle East, and Africa.

Dr. Jyoti Wadhwa is one of India's most accomplished medical oncologists and precision oncology specialists, bringing over 32 years of dedicated clinical experience in comprehensive, evidence-based cancer care. A Fellow of the Royal College of Physicians (FRCP), Edinburgh, and graduate of AIIMS with a DM in Medical Oncology, she stands among the country's foremost cancer specialists. Her advanced international training at Imperial College London has further strengthened her expertise in cutting-edge oncological practice. As Principal Lead – Medical Oncology & Precision Oncology at Apollo Athenaa Women's Cancer Centre in Defence Colony, South Delhi, Dr. Wadhwa delivers a sophisticated, science-driven approach to cancer treatment. She specializes in medical oncology, precision oncology, and the full spectrum of women's cancers—breast, ovarian, cervical, and endometrial cancer. Her clinical arsenal includes chemotherapy, cancer immunotherapy, targeted therapy, antibody-drug conjugates, hormone therapy, and CAR-T cell therapy. She is a passionate advocate of molecular profiling, genetic testing, biomarker analysis, and liquid biopsies, tailoring every treatment plan to the individual tumor biology and patient circumstances. Dr. Wadhwa has built a robust international patient practice, welcoming patients from the Gulf Cooperation Council (GCC), North Africa, and across South Asia seeking world-class cancer care. Her warm, empathetic communication style—fluent in both English and Hindi—puts patients and families at ease during what can be a daunting journey. She is recognized not only as a clinician but also as an oncology educator and author of two highly regarded medical books, having delivered over 400 scientific lectures at national and international conferences. Apollo Athenaa Women's Cancer Centre is a dedicated tertiary cancer facility embedded within the Apollo Hospitals network, known for its state-of-the-art diagnostic imaging, molecular pathology laboratories, multidisciplinary tumor boards, and patient-centered supportive care. The centre's commitment to precision medicine, combined with Apollo's international patient infrastructure, makes it an ideal destination for international patients seeking personalized oncology care. International patients benefit from streamlined visa support, translation services, and coordinated follow-up care. Whether you are seeking a second opinion, initial diagnosis and staging, or complex multimodal treatment, Dr. Wadhwa and Apollo Athenaa provide the clinical excellence and compassionate support that international patients expect. With Gaf Healthcare's coordination, your entire care journey—from virtual consultation through in-person treatment and remote follow-up—is seamlessly managed.

Dr. Sudha Sinha is a Clinical Director, Head of Department, and Senior Consultant in Medical Oncology with over 23 years of clinical experience spanning both the United States and India. She holds American Board Certifications in Internal Medicine, Hematology, and Medical Oncology, along with ECFMG Certification—credentials reflecting her rigorous training at prestigious American institutions including St. Barnabas Medical Center and Tufts University School of Medicine. Dr. Sinha brings deep expertise in the management of solid tumors, hematologic malignancies, and complex cancer care. Her clinical focus encompasses chemotherapy, cancer immunotherapy, CAR-T cell therapy, and targeted therapy across a broad spectrum of malignancies including breast cancer, gynecologic cancers, leukemia, myeloma, lung cancers, gastrointestinal cancers, and sarcomas. She is recognized for her evidence-based, compassionate approach to treatment and her commitment to holistic cancer management, including palliative care and fertility preservation for women with cancer. Dr. Sinha has established herself as a trusted oncologist for international patients seeking specialized cancer care. Her bilingual expertise (English and regional Indian languages) and experience managing patients from the Gulf, Africa, and across the Indian subcontinent enable her to provide culturally sensitive, personalized treatment plans. She works seamlessly with international medical coordinators to ensure a smooth experience for patients traveling to India for cancer treatment. At Yashoda Hospital in Hyderabad, she leads a comprehensive oncology service equipped with modern diagnostic and treatment technologies. Yashoda Hospital is known for its patient-centered care, international quality standards, and seamless coordination for international patients. The hospital's location in Hyderabad—a major medical hub with excellent connectivity—makes it an ideal destination for cancer patients seeking world-standard care at affordable costs. International patients benefit from dedicated support services, transparent communication, and evidence-based treatment protocols overseen by Dr. Sinha and her team. For patients seeking advanced cancer treatment with a physician who combines American-trained rigor with deep Indian clinical experience, Dr. Sinha offers a compelling option. Her track record of managing complex cases and her commitment to staying current with the latest oncologic advances make her a preferred choice for international medical tourists seeking comprehensive, compassionate cancer care in India.

Dr. Ankit Jain is a Senior Consultant in Medical Oncology at Indraprastha Apollo Hospital, New Delhi, bringing over 22 years of distinguished clinical experience in cancer care. He holds an MBBS from Maulana Azad Medical College Delhi, MRCP qualifications in Medicine and Oncology from London, and an MSc in Oncology from Birmingham, United Kingdom. His training across prestigious UK and Indian institutions has shaped a career devoted to evidence-based, internationally-standard oncological practice. Dr. Jain specializes in comprehensive cancer management spanning chemotherapy, cancer immunotherapy, targeted therapy, and hormonal treatments across multiple cancer types. His clinical expertise covers bowel cancer, lung cancer, breast cancer with hormone therapy, kidney cancer, pancreatic cancer, and gynaecologic malignancies. He is skilled in CAR-T cell therapy, radiation therapy coordination, and personalized treatment planning. His practice is underpinned by continuous engagement with the latest oncological advances and a commitment to multidisciplinary care protocols. International patients form a meaningful part of Dr. Jain's patient base, particularly from the Gulf region, Africa, and South Asian countries. He communicates fluently in English, Hindi, and Punjabi, ensuring that patients from diverse backgrounds feel supported and informed throughout their treatment journey. His approachable clinical demeanour combined with his depth of knowledge makes him a trusted choice for patients seeking second opinions and comprehensive cancer care plans. Indraprastha Apollo Hospital in New Delhi is one of India's leading tertiary cancer centres, equipped with advanced imaging, robotic-assisted surgical suites, and dedicated oncology wings. The hospital maintains NABH and JCI accreditation, international patient support services, and robust follow-up protocols. Dr. Jain's affiliation with Apollo Athena Women's Cancer Centre further underscores his commitment to specialized oncological care. Dr. Jain is an active member of the American Society of Clinical Oncologist, European Society of Medical Oncologist, and the British Medical Association, maintaining alignment with global best practices. International patients choosing to work with him benefit from a clinician trained in both NHS and Indian healthcare systems, ensuring world-class standards and culturally sensitive care.

Dr. Karanam Ashok Kumar is a Senior Consultant Haemato-Oncologist and Bone Marrow Transplant Specialist at Yashoda Hospitals, Hyderabad, one of India's leading centres for complex hematological malignancies. With more than 21 years of clinical practice, he holds an MBBS from S.V. Medical College Tirupati, a DNB in Medical Oncology and a DM in Clinical Hematology from the prestigious Nizam's Institute of Medical Sciences, Hyderabad, complemented by advanced post-doctoral training at Christian Medical College, Vellore. His deep expertise in hemato-oncology and transplantation medicine has made him a recognised authority in the field. Dr. Ashok Kumar has personally conducted over 400 bone marrow transplants spanning autologous, allogeneic, and haploidentical procedures in both adult and paediatric populations. His clinical practice encompasses acute and chronic leukemias, lymphomas, multiple myeloma, myelodysplastic syndromes, thalassaemia, sickle cell disease, aplastic anaemia, and amyloidosis. He combines rigorous diagnostic precision with innovative treatment protocols, ensuring optimal outcomes even in complex and rare haematological disorders. His work at the Mehdi Nawaj Jung Regional Cancer Center further expands his capacity to manage the most challenging cases. Dr. Ashok Kumar has earned international recognition through his management of patients from across the Gulf Region, Africa, and South Asia. He is fluent in English, Hindi, and Telugu, making him accessible to diverse patient populations. His patient-centric approach ensures thorough counselling, transparent treatment planning, and compassionate care throughout the transplantation journey and long-term follow-up. Many international patients choose his care for the combination of technical excellence and personalised attention. Yashoda Hospitals, Somajiguda, Hyderabad, is equipped with state-of-the-art haemato-oncology and transplantation units, advanced diagnostic laboratories, and dedicated isolation facilities essential for bone marrow transplant recipients. The hospital maintains rigorous infection control protocols and offers seamless coordination for international patients, including visa assistance, accommodation guidance, and multilingual support staff. Hyderabad's robust medical infrastructure and cost-effective treatment make it an attractive destination for international patients seeking world-standard care at accessible rates. For international patients considering bone marrow transplantation or complex haemato-oncology treatment, Dr. Ashok Kumar's combination of advanced training, high transplant volumes, and proven outcomes offers both safety and success. His association with major professional bodies—the Indian Society of Blood and Marrow Transplantation and the Asia Pacific Society of Blood and Marrow Transplantation—reflects his commitment to evidence-based practice and continuous professional development. Gaf Healthcare facilitates seamless consultation and treatment coordination for patients worldwide.

Dr. Mohit Sharma is a Clinical Director and Head of the Department of Medical Oncology at Marengo Asia Hospitals in Faridabad, bringing over 20 years of dedicated expertise in comprehensive cancer care. He earned his MBBS and MD in Medicine from Government Medical College, Jammu, and completed specialized training in medical oncology through academic posts at VMMC & Safdarjung Hospital, New Delhi, and a postdoctoral fellowship at the renowned Tata Memorial Hospital, Mumbai. Throughout his career, Dr. Sharma has developed deep clinical competence across a wide spectrum of malignancies, including head and neck, breast, lung, gastrointestinal, genitourinary, gynecological, bone, and soft tissue cancers. He is particularly skilled in precision oncology approaches, including chemotherapy, cancer immunotherapy, targeted therapy, and emerging modalities such as CAR-T cell therapy. His experience spans hormone therapy for breast, gynecological, and prostate cancers, allowing him to tailor treatment plans to individual patient biology and disease stage. Dr. Sharma has earned a strong reputation for patient-centric care and regularly treats international patients from the Gulf region, Africa, and SAARC countries seeking specialized oncology services in India. His ability to communicate in English and Hindi facilitates seamless consultations with diverse patient populations. At Marengo Asia Hospitals, he directs a comprehensive oncology department equipped with modern diagnostic and therapeutic facilities, ensuring that both domestic and international patients receive evidence-based, multidisciplinary cancer care. Marengo Asia Hospitals is a modern, multi-specialty tertiary care center in Faridabad with advanced oncology infrastructure, dedicated ICU support, and an established international patient services team. The hospital's strategic location near Delhi makes it accessible for patients traveling from abroad. Dr. Sharma's leadership of the oncology department and his active membership in the European Society of Medical Oncology (ESMO), Indian Society of Oncology, and the Indian Cooperative Oncology Network (ICON) reflect his commitment to maintaining international standards of cancer care. For international patients considering cancer treatment in India, Dr. Sharma offers a proven combination of extensive experience, modern clinical practice, and a compassionate approach to oncology management. His track record at prestigious institutions like Tata Memorial Hospital and Fortis Healthcare demonstrates consistent excellence in delivering outcomes-focused cancer treatment.

Dr. Rajeev Vijayakumar is the Head of Department and Senior Consultant in Medical Oncology at Gleneagles Hospitals, Bengaluru, one of India's leading multispecialty centers. With over 20 years of clinical experience, he has established himself as a trusted specialist in the diagnosis and management of blood cancers, solid tumors, and complex hematological disorders. His credentials span both India and the United Kingdom, including MRCP certification and ESMO (European Society for Medical Oncology) accreditation, reflecting his commitment to global oncological standards. Dr. Rajeev's clinical depth extends across a comprehensive range of advanced cancer therapies. He specializes in hemato-oncology, bone marrow transplantation, conventional chemotherapy, cancer immunotherapy, targeted molecular therapy, CAR-T cell therapy, and hormone therapy for breast cancer. His approach combines evidence-based protocols with personalized treatment planning, ensuring each patient receives care tailored to their tumor biology and clinical profile. The breadth of his expertise allows him to manage both common and rare malignancies with equal proficiency. Dr. Rajeev has developed a reputation for welcoming and expertly managing international patients from across the Gulf, Africa, and Southeast Asia. He understands the unique logistical and emotional needs of patients traveling for cancer care and ensures seamless coordination from initial consultation through follow-up. His multilingual capabilities—English, Hindi, and Kannada—facilitate clear communication with diverse patient populations. Patients consistently praise his ability to transform medical consultations into meaningful dialogues where concerns are heard and treatment options are explained with clarity and compassion. Gleneagles Hospitals Bengaluru is a NABH-accredited, 350-bed multispecialty facility equipped with advanced diagnostic and therapeutic technologies, including cutting-edge oncology suites, dedicated hemato-oncology units, and state-of-the-art intensive care. The hospital's international patient services desk coordinates visa support, accommodation, and travel logistics, making it an ideal destination for cancer patients seeking world-standard care in India. Dr. Rajeev's leadership within this infrastructure ensures that international patients benefit from both his individual expertise and the hospital's comprehensive oncological ecosystem. For patients from the Middle East, Africa, and SAARC regions seeking specialized cancer care, Bengaluru offers cost-effective, high-quality treatment without geographical compromise.

Dr. Shefali Sardana is a Senior Consultant in Medical Oncology at Indraprastha Apollo Hospital in New Delhi with over 20 years of clinical expertise in cancer care. She holds an MBBS, MD in Medicine, and DNB in Medical Oncology, alongside recent fellowships in colorectal cancer management from Charité University Hospital in Berlin (2024) and kidney cancer treatment in Singapore (2019). Her qualifications and continuous engagement with international training programmes reflect her commitment to staying at the forefront of modern oncology. Dr. Sardana specialises in the comprehensive management of gastrointestinal, hepato-pancreato-biliary, and genitourinary cancers, with additional expertise in breast and gynaecological malignancies. She is highly skilled in delivering chemotherapy, immunotherapy, targeted therapy, hormone therapy, and CAR-T cell therapy. Throughout her career, she has administered and supervised over 40,000 cycles of systemic therapy and treated more than 15,000 cancer patients across early-stage, locally advanced, and metastatic disease settings. Her multidisciplinary approach to complex solid organ malignancies ensures individualised, evidence-based treatment plans. Dr. Sardana is an experienced clinical researcher and Principal Investigator in international oncology trials, with presentations at major global forums including ASCO-GI. She actively contributes to national cancer guidelines and medical textbooks, strengthening India's oncology knowledge base. She welcomes international patients from the Gulf region, Africa, and neighbouring countries, and is fluent in both English and Hindi, ensuring clear communication throughout the treatment journey. Her patient-centred philosophy combines advanced systemic therapy expertise with compassionate care. Indraprastha Apollo Hospital, where Dr. Sardana practises, is a world-renowned institution equipped with state-of-the-art oncology facilities, advanced diagnostic imaging, and robust supportive care services. The hospital's NABH and JCI accreditation, combined with dedicated international patient support, makes it an ideal destination for cancer care. Apollo Athenaa Women's Cancer Centre, affiliated with her practice, further specialises in breast and gynaecological malignancies. International patients choosing Dr. Sardana benefit from cutting-edge cancer treatment in a highly regulated healthcare environment, combined with the affordability and clinical depth that Indian oncology uniquely offers.

Dr. S. Viswanath is a Senior Consultant in Medical Oncology with over 17 years of dedicated experience in cancer medicine. A former Brigadier in the Indian Armed Forces Medical Services, he brings exceptional clinical discipline and compassionate care to every patient encounter. He holds an MD in General Medicine from Command Hospital (Airforce), Bangalore, and a DM in Medical Oncology from the prestigious Cancer Institute (WIA) in Adyar, Chennai—institutions recognized for rigorous oncological training. Dr. Viswanath has managed a broad spectrum of malignancies across his career, spanning chemotherapy, targeted therapy, hormone therapy, immunotherapy, and advanced CAR-T cell therapy. His academic contributions include published research on rheumatoid arthritis, bronchogenic carcinoma, and lymphoma in peer-reviewed journals, demonstrating his commitment to evidence-based oncology. Throughout his military tenure, he served in progressively senior roles—from Assistant Professor to Senior Advisor and Professor—at premier military hospitals across India, including Command Hospital (Western Command) and Army Hospital (Research & Referral) in New Delhi. His leadership credentials include serving as Commandant of Military Hospital, Chennai, underscoring his organizational and clinical expertise. At Rela Hospital's Cancer Centre in Chennai, Dr. Viswanath treats international patients from the Gulf region, Africa, and South Asia seeking world-standard oncological care. He works closely with multidisciplinary teams to develop personalized treatment plans that balance aggressive cancer control with quality of life. His proficiency in English, Hindi, and Tamil facilitates seamless communication with patients from diverse backgrounds. International patients particularly value his methodical approach to complex cases and his ability to integrate the latest chemotherapy protocols with emerging immunotherapeutic strategies. Rela Hospital is a Joint Commission International (JCI)-accredited centre of excellence located in Chennai, a major medical tourism hub in South India. The hospital's Cancer Centre is equipped with advanced diagnostic imaging, dedicated oncology wards, and supportive care facilities that meet international standards. The institution's strong reputation for outcomes in breast cancer, hematologic malignancies, and solid tumours, combined with comprehensive patient support services and transparent pricing, makes it an attractive destination for international patients. For those seeking expert cancer management with a physician who combines military-honed precision with cutting-edge oncological science, Dr. Viswanath offers both clinical depth and the reassurance of treatment at a globally recognized facility.

Dr. Ponni Sivaprakasam is a Senior Consultant in Medical Oncology at Gleneagles Global Health City in Chennai, bringing over 17 years of clinical expertise in cancer care and blood disorders. She holds an MRCPCH qualification from the Royal College of Paediatrics and Child Health, London, and has completed specialized fellowships in clinical pediatric hematology-oncology and bone marrow transplantation from leading UK institutions including The Hospital for Sick Children and Bristol Royal Hospital for Children. Her international distinction includes recognition as a JACIE inspector by the European Blood and Marrow Transplantation group, a role that involves inspecting and accrediting bone marrow transplant centers worldwide to maintain global quality standards. Dr. Sivaprakasam's clinical practice encompasses the full spectrum of medical oncology, with particular expertise in pediatric hemato-oncology, bone marrow and stem cell transplantation, chemotherapy protocols, cancer immunotherapy, and targeted therapies including CAR-T cell therapy. She has published peer-reviewed research in high-impact journals on mesenchymal stromal cell therapy for graft-versus-host disease and adenovirus infection in transplant recipients, demonstrating her engagement with advancing cancer and transplant medicine. Her case management spans complex pediatric and adult cancer patients, and she leads multidisciplinary teams in treatment planning and long-term follow-up care. International patients from the Gulf, Africa, and South Asia find Dr. Sivaprakasam's clinic a welcoming environment. She communicates fluently in English, Hindi, and Tamil, and her experience managing cross-border patient logistics is substantial. Patients appreciate her systematic approach to diagnosis, evidence-based treatment planning, and transparent communication about prognosis and options. The clinic coordinates closely with Gaf Healthcare to arrange remote consultations, medical record review, and seamless admission processes for patients traveling to Chennai for treatment. Gleneagles Global Health City is a JCI-accredited, multi-specialty tertiary care facility with dedicated oncology and transplant units, advanced diagnostic imaging, and on-site blood bank facilities. The hospital's international patient services team manages visa support, accommodation liaison, and currency exchange for overseas visitors. The institution's commitment to evidence-based practice and infrastructure for complex cancer care makes it an established choice for international patients seeking comprehensive oncology management in South India. International patients should know that Dr. Sivaprakasam's clinic operates with clear pathways for virtual consultation, document review prior to travel, and pre-treatment planning. Treatment timelines and costs are discussed openly, and follow-up care can be coordinated with local oncologists after the patient returns home. Chennai's modern airport connectivity and lower cost of care compared to Western centers make it an accessible option for families managing serious cancer diagnoses.

Dr. Vishnu Hari is an Associate Director and Head of Unit I in Medical Oncology, Haematology, and Bone Marrow Transplantation at Sarvodaya Hospital in Faridabad. With more than 16 years of clinical experience, he brings deep expertise in diagnosing and treating a broad spectrum of solid and haematological malignancies. His comprehensive training at the Regional Cancer Centre, Trivandrum, combined with his qualifications in internal medicine and general medicine from Government Medical College, Calicut, has established a strong academic and clinical foundation. Dr. Hari's clinical proficiency encompasses the management of leukaemia, lymphoma, myeloma, breast cancer, sarcoma, gastrointestinal cancers, and genitourinary cancers. He is highly skilled in advanced treatment modalities including stem cell transplantation, cancer immunotherapy, targeted therapy, CAR-T cell therapy, and precision oncology. His expertise in oncology critical care ensures that patients with complex presentations receive comprehensive, multidisciplinary support throughout their treatment journey. International patients from the Gulf region, Africa, and South Asia seek Dr. Hari's care for complex oncology cases. He maintains a patient-centric approach, taking time to explain treatment options in clear language and ensuring families understand the clinical pathway. His experience treating international patients has equipped him with cultural sensitivity and a commitment to coordinating care seamlessly across borders. Sarvodaya Hospital, located in Sector 8 of Faridabad, is an established tertiary cancer centre with state-of-the-art oncology facilities, dedicated haematology-BMT units, and comprehensive critical care infrastructure. The hospital prioritizes international patient support with dedicated consultation coordinators, translation services, and streamlined admission processes. Patients from overseas benefit from the hospital's integration of global treatment protocols with local expertise, making complex cancer care both accessible and affordable. International patients considering treatment in India should know that Dr. Hari's unit maintains standards aligned with ASCO and ESMO guidelines, ensuring evidence-based care regardless of origin. Gaf Healthcare can facilitate initial video consultations, arrange document reviews, and coordinate logistics for international patients seeking second opinions or comprehensive oncology management.

Dr. Bhuvan Chugh is a Lead Consultant in Medical Oncology at Indraprastha Apollo Hospital in New Delhi, bringing over 15 years of clinical excellence to cancer care. He holds qualifications in MBBS, DNB (Medicine), and DNB (Medical Oncology), establishing a robust foundation in internal medicine and specialized oncology practice. Dr. Chugh is recognised for his evidence-based, empathetic approach to patient care, underpinned by a commitment to clarity and confidence in medical decision-making. Dr. Chugh specialises in breast cancer and thoracic cancer management, with particular expertise in chemotherapy, cancer immunotherapy, targeted therapy, and hormone therapy for breast cancers. A key focus of his practice is precision-led oncology—integrating genomic sequencing and molecular oncology findings to guide personalised treatment strategies. His notable clinical work includes CSF-based genomic sequencing management in EGFR-mutant lung cancer with leptomeningeal disease, presented at ALKlinic 2025 and published in the Journal of Liquid Biopsy. He previously served as Principal Consultant at Max Super Specialty Hospital (Saket and Gurugram), and as Past Convenor of the Max Healthcare–Foundation Medicine India Molecular Tumor Board, contributing to multidisciplinary oncology decision-making. Dr. Chugh treats a diverse international patient population, including patients from the Gulf region, Africa, and South Asia seeking specialist cancer care. His fluency in English and Hindi ensures clear communication with patients across borders. He is an active member of leading international oncology societies—American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), and International Association for the Study of Lung Cancer (IASLC)—keeping his practice aligned with global standards. His work has been presented at ASCO and ESMO conferences, and he was recognised with the ESMO Asia 2024 Best Poster Award. Indraprastha Apollo Hospital, where Dr. Chugh practices, is a major tertiary-care centre in the Delhi–NCR region with state-of-the-art oncology infrastructure, advanced molecular diagnostics, and dedicated international patient services. The hospital's affiliation with Apollo Athenaa Women's Cancer Centre further strengthens its breast cancer management capabilities. International patients choosing Dr. Chugh benefit from a hospital ecosystem designed to support complex cancer cases, alongside a physician who practises evidence-based protocols informed by global oncology consensus. For patients seeking specialist oncology care with molecular precision and a patient-first philosophy, Dr. Chugh at Apollo Hospitals offers continuity, expertise, and access to cutting-edge diagnostic and therapeutic options.

Dr. Anshul Gupta is a Senior Consultant in Medical Oncology at Indraprastha Apollo Hospital, Delhi NCR, with over 12 years of dedicated cancer care experience. He holds a DM in Medical Oncology from AIIMS, New Delhi, the country's leading cancer medicine institute, combined with an MD in General Medicine and MBBS. Throughout his career, he has treated more than 8,000 cancer patients and administered over 40,000 cycles of chemotherapy, targeted therapy, and immunotherapy, establishing himself as a trusted oncology specialist. Dr. Gupta specializes in a comprehensive range of modern systemic therapies, including chemotherapy, cancer immunotherapy, targeted therapy, hormone therapy, CAR-T cell therapy, and precision oncology. His particular expertise spans breast cancer, genitourinary cancers (prostate and kidney cancer), lung cancer, and soft tissue sarcomas. He integrates international evidence-based guidelines from ASCO and ESMO with practical, patient-centered care tailored to the Indian healthcare context. His international preceptorship in lung cancer at Peter MacCallum Cancer Centre in Melbourne, Australia (2023) further deepens his knowledge of cutting-edge treatment protocols. Dr. Gupta is experienced in treating international patients from the Gulf region, Africa, and South Asia. He communicates fluently in English and Hindi, and Gaf Healthcare's multilingual support team ensures seamless coordination for overseas patients. His patient-centric approach, combined with rigorous clinical training, has earned him a rating of 4.8/5 from over 80 patient reviews. He is a founding member of the Genito-Urinary Cancer Advocacy Network India (GU-CAN India), reflecting his commitment to advancing cancer care beyond the clinic. Indraprastha Apollo Hospital in Delhi NCR is one of India's leading multispecialty healthcare facilities, equipped with state-of-the-art oncology units, advanced diagnostic imaging, molecular pathology laboratories, and dedicated international patient services. The hospital holds international accreditations and offers seamless coordination for medical tourists seeking world-class cancer treatment in India.

Dr. Viraj Nevrekar is a Senior Consultant in Medical Oncology and Hemato-Oncology with over 11 years of dedicated clinical experience in treating complex and advanced cancers. A graduate of the All India Institute of Medical Sciences (AIIMS), New Delhi — one of India's most respected medical institutions — he holds both an MD in Medicine and a DM in Medical Oncology, credentials that reflect his rigorous training in oncological care. His additional ECMO certification from Switzerland underscores his commitment to staying at the forefront of global cancer treatment standards. Dr. Nevrekar brings comprehensive clinical depth across all major oncology disciplines. His practice encompasses bone marrow transplantation, chemotherapy protocols, immunotherapy, targeted therapies, and hormone-based treatments for breast, prostate, and gynecologic malignancies. He manages high-volume patient cases and applies evidence-based clinical judgment to design personalized treatment plans for each patient, ensuring outcomes that balance efficacy with quality of life. International patients — particularly those from the Gulf region, Africa, and Southeast Asia — choose Dr. Nevrekar for his patient-centric approach and clear communication across English, Hindi, and Marathi. He has established strong working relationships with leading corporate hospital networks and maintains alignment with international oncology literature, making him a trusted resource for patients seeking second opinions or comprehensive management of advanced disease. Dr. Nevrekar practices at Gleneagles Global Hospitals in Mumbai's Parel neighborhood, a NABH-accredited facility known for its advanced oncology infrastructure, dedicated cancer care units, and seamless coordination for international patients. The hospital's robust support systems, multilingual staff, and comprehensive diagnostic capabilities make it an ideal destination for patients requiring specialized cancer treatment combined with the comfort of a world-class medical environment. For international patients considering treatment in India, Dr. Nevrekar's combination of elite training, extensive clinical experience, and affordability — with consultation fees at just USD 65 — represents excellent value without compromise on clinical rigor or patient safety.

Dr. Divya Doval is a Senior Consultant in Haemato-Oncology and Bone Marrow Transplant at BLK-Max Super Speciality Hospital, New Delhi. With over 11 years of clinical experience and an exceptional track record of more than 1,500 successful transplants, she has established herself as a leading bone marrow transplant specialist in India. Her academic credentials include MBBS, MRCPCH from the Royal College of Paediatrics and Child Health (UK), and specialized fellowships in CAR-T Cell Therapy from Royal Marsden Hospital in London and in Haemato-Oncology and Bone Marrow Transplant from BLK Super Speciality Hospital. Dr. Doval's clinical expertise spans the full spectrum of bone marrow transplant procedures, including allogeneic, autologous, and haploidentical transplants with matched sibling and unrelated donors. She is particularly skilled in managing acute leukemia, myelodysplastic syndromes, bone marrow failure syndromes, and pediatric conditions such as thalassemia and aplastic anemia. Her proficiency in CAR-T cell therapy represents one of the most advanced immunotherapeutic approaches in hematologic malignancies. Her approach to case selection, donor matching, and post-transplant management reflects both evidence-based protocols and personalized clinical judgment honed over thousands of procedures. International patients from the Gulf region, Africa, and SAARC countries seek Dr. Doval's expertise for complex hematologic and transplant management. She is fluent in English and Hindi, and the hospital provides dedicated international patient support to ensure seamless communication and care coordination. Many patients return for follow-up management, reflecting the trust built through transparency, clinical excellence, and compassionate care. The Centre for Bone Marrow Transplant at BLK-Max has become a preferred destination for families seeking second opinions and definitive transplant intervention. BLK-Max Super Speciality Hospital in New Delhi is a NABH-accredited, multi-specialty tertiary care centre with world-class infrastructure for transplant care. The hospital features dedicated transplant wards with HEPA-filtered isolation units, advanced laboratory facilities for HLA typing and chimerism monitoring, and a robust supportive care team including specialized nutritionists, psychologists, and infectious disease specialists. The Centre for Bone Marrow Transplant operates with modern protocols aligned with international guidelines, and the hospital maintains comprehensive records for long-term follow-up and outcome tracking. For international patients, the hospital's international desk arranges logistics, accommodation liaisons, and coordinated care schedules. When considering bone marrow transplant abroad, international patients should know that Dr. Doval's centre offers transplantation at a cost-effective level compared to Western centres, without compromise on sterility standards, donor selection rigor, or post-transplant follow-up intensity. The hospital's experience with patients from multiple countries has refined protocols for managing time-zone coordination, remote consultations, and ensuring continuity of care upon return home.

Dr. Kumar Rishikesh is a Senior Consultant in Medical Oncology at Indraprastha Apollo Hospital, New Delhi, with over 10 years of dedicated clinical experience in cancer care. He holds an impressive educational background that includes MBBS, MD (Medicine), DNB in Medical Oncology, and a prestigious Fellowship in Medical Oncology and Hematology from Princess Margaret Cancer Centre at the University of Toronto, Canada. This international training has equipped him with expertise in cutting-edge oncological practices and a global perspective on cancer treatment. Dr. Rishikesh brings substantial clinical depth across a comprehensive range of malignancies, from solid tumors like breast, gastric, and gynecologic cancers to hematologic conditions including leukemia, lymphoma, and myeloma. His areas of specialization encompass conventional chemotherapy, advanced immunotherapy, targeted molecular therapy, hormone-based treatments, and emerging modalities such as CAR-T cell therapy. He actively participates in multidisciplinary molecular tumor boards and has contributed to research on neoadjuvant chemotherapy response and treatment optimization, reflecting his commitment to evidence-based, personalized cancer care. Dr. Rishikesh is well-accustomed to treating international patients from the Gulf region, Africa, and South Asia seeking specialized oncology care. His fluency in English, Hindi, Bengali, and Maithili enables seamless communication with patients from diverse linguistic backgrounds, ensuring clear discussion of treatment plans, prognosis, and support options. He approaches each patient with compassion and takes time to understand their individual circumstances, cultural needs, and treatment preferences. Indraprastha Apollo Hospital is one of India's leading multispecialty institutions, equipped with state-of-the-art oncology facilities, advanced imaging and laboratory capabilities, and a strong multidisciplinary team. The hospital's commitment to international patient care, NABH accreditation, and robust follow-up infrastructure make it a trusted destination for comprehensive cancer treatment. Dr. Rishikesh's practice there combines world-standard diagnostic protocols, modern chemotherapy regimens, and compassionate supportive care, making it an excellent choice for international patients seeking reliable, evidence-based oncology treatment in South Asia.

Dr. Akash Khandelwal is a distinguished consultant hematologist and hemato-oncologist with over 10 years of clinical expertise in complex blood disorders and hematologic malignancies. As Consultant and Unit Head of the Department of Hematology, Hemato-Oncology, and Bone Marrow Transplant at Fortis Hospital Shalimar Bagh in New Delhi, he brings academic rigor from his DM training at the prestigious All India Institute of Medical Sciences (AIIMS), one of India's foremost medical institutions, combined with profound practical experience in advanced transplant medicine. Dr. Khandelwal has personally supervised and conducted over 100 bone marrow transplants, including autologous stem cell transplants, matched sibling donor, matched unrelated donor, and haploidentical donor procedures. His clinical depth spans the full spectrum of hematologic conditions: acute and chronic leukemias, lymphomas, multiple myeloma, myelodysplastic syndromes, thalassemia, sickle cell disease, aplastic anemia, and myeloproliferative neoplasms. He is also experienced in cutting-edge immunotherapy, including CAR-T cell therapy, positioning him at the forefront of modern blood cancer treatment. Dr. Khandelwal treats a substantial number of international patients from the Gulf region, Africa, and South Asia who seek specialized bone marrow transplant and hemato-oncology care in India. His hospital affiliation with Fortis Shalimar Bagh—a major multispecialty center in New Delhi—ensures comprehensive support for complex cases, including dedicated transplant units, advanced diagnostic facilities, and seamless coordination for overseas patients. He also maintains active associations with other leading institutions including BLK-MAX Hospital and Action Balaji Cancer Hospital in New Delhi, further expanding his clinical network. Fortis Hospital Shalimar Bagh is accredited under NABH standards and maintains international protocols for patient care. The hospital offers 24/7 ICU support, state-of-the-art imaging, and dedicated hemato-oncology wards essential for transplant recovery. For international patients, the hospital has a well-established medical tourism desk and provides language support in English and regional languages. Patients traveling to New Delhi for bone marrow transplant or blood cancer treatment benefit from the city's well-connected international airport, accessible accommodation, and robust follow-up care infrastructure. When seeking bone marrow transplant or hemato-oncology consultation in India, Dr. Khandelwal's combination of AIIMS training, high transplant volume, and systematic approach to international patient care makes Fortis Shalimar Bagh a dependable destination. International patients should know that bone marrow transplant timelines typically span 3–4 weeks for donor evaluation and transplant, with post-transplant stay extending to 4–8 weeks depending on complications. Most international patients coordinate their visits through Gaf Healthcare for seamless booking and in-country logistics.

Dr. Ghazal Tansir is a Senior Consultant in Medical Oncology at Indraprastha Apollo Hospital in New Delhi, bringing over 9 years of focused expertise in cancer diagnosis and treatment. She holds advanced qualifications including a DM in Medical Oncology, MD in Internal Medicine, DNB, and MBBS, establishing a robust academic and clinical foundation. Her training and sustained practice reflect a deep commitment to staying at the forefront of oncological science. Dr. Tansir specializes in a comprehensive range of cancer types including breast cancer, lung cancer, head and neck cancers, genitourinary malignancies, and sarcoma. She is highly proficient in evidence-based treatment modalities including chemotherapy, cancer immunotherapy, targeted molecular therapy, hormone therapy, and emerging CAR-T cell therapy protocols. Her clinical approach emphasizes personalized treatment planning, integrating the latest research findings with individual patient circumstances to optimize both efficacy and quality of life. She regularly treats international patients from the Gulf region, Africa, and South Asia, providing clear multilingual communication and coordinated care pathways. Her patient-centric philosophy ensures families are supported throughout the cancer journey with transparent information and compassionate clinical guidance. Indraprastha Apollo Hospital is a premier multi-specialty tertiary care centre known for its advanced oncology infrastructure, dedicated cancer wards, state-of-the-art radiation and chemotherapy units, and integrated supportive care. The hospital's international patient services and established ties with global oncology networks make it an ideal destination for complex cancer management. International patients choosing Dr. Tansir benefit from seamless coordination through Gaf Healthcare, ensuring smooth travel logistics, pre-arrival case review, and comprehensive follow-up care planning.

Dr. Bhawna Dahiya is a Consultant in Medical Oncology at Sarvodaya Hospital in Faridabad, with over 8 years of dedicated clinical experience in cancer care. She holds a DM in Medical Oncology from Government Kilpauk Medical College, Chennai, and is certified by the European Society of Medical Oncology (ESMO), reflecting her commitment to evidence-based, contemporary oncology practice. Dr. Dahiya brings deep expertise across the full spectrum of medical oncology, with specialization in breast cancer, gynaecologic malignancies, thoracic cancers, gastrointestinal malignancies, and lymphoproliferative disorders. She is proficient in chemotherapy administration, targeted therapy, cancer immunotherapy, and CAR-T cell therapy. Her clinical approach emphasizes personalized treatment planning, oncologic emergency management, and supportive palliative care to optimize patient outcomes. She welcomes international patients from the Gulf region, Africa, and South Asia, and is experienced in coordinating multidisciplinary care for overseas families. Her calm, patient-centred approach helps international patients navigate complex treatment decisions with confidence. She is fluent in English and Hindi, facilitating clear communication with diverse patient populations. Sarvodaya Hospital, where Dr. Dahiya practices, is a modern, NABH-accredited facility in Sector 8, Faridabad, offering advanced oncology infrastructure, dedicated cancer wards, ICU support, and a dedicated international patient coordination team. The hospital's proximity to Delhi makes it accessible for patients from across India and the world. International patients benefit from streamlined admission processes, telemedicine pre-consultation, and comprehensive discharge planning for continued care at home.